Qlarity Imaging and Blackford Partner to Bring QuantX™ Diagnostic AI to More Breast Radiologists via Blackford Platform™, Helping More Patients in Need


Qlarity Imaging, a leading innovator in artificial intelligence (AI) diagnostics and portfolio company of Paragon Biosciences, and Blackford, the provider of the dedicated platform for medical imaging applications and AI, today announced their agreement to integrate QuantX™ within Blackford’s curated marketplace. The partnership will combine the implementation and maintenance gains of a platform-based approach with the increased accuracy and improved reader performance benefits of QuantX™ for breast MRI interpretation to help deliver better outcomes for more radiologists, health systems, and most importantly patients. The integration will feature the new cloud-based, vendor neutral format of QuantX™, which is currently in development and pending application seeking FDA clearance.

Read More

Next Post

GoHealth and GoodRx Announce Exclusive Medicare Agreement

GoHealth, Inc. (GoHealth) (NASDAQ: GOCO), a leading health insurance marketplace and Medicare-focused digital health company, and GoodRx, Inc. (NASDAQ: GDRX), America’s leading resource for healthcare savings, today announced an exclusive agreement to bring GoHealth’s Medicare enrollment and engagement solutions directly to GoodRx users on the GoodRx platform. Of the nearly […]